Today: 30 April 2026
XPeng (XPEV) Soars Up to 18% on Humanoid ‘IRON’ Robot and Robotaxi Momentum; Q3 Earnings Set for Nov. 17
11 November 2025
3 mins read

XPeng (XPEV) Soars Up to 18% on Humanoid ‘IRON’ Robot and Robotaxi Momentum; Q3 Earnings Set for Nov. 17

November 11, 2025 — XPeng Inc. (NYSE: XPEV; HKEX: 9868) ripped higher today as enthusiasm around the company’s humanoid robot IRON and a fast‑developing robotaxi program spilled over from last week’s AI Day into markets. Hong Kong–listed shares jumped as much as ~18% intraday, while U.S. ADRs traded sharply higher, marking XPeng’s biggest one‑day pop in over two years, according to multiple market reports.

What happened today (Nov. 11, 2025)

  • Hong Kong closes strong: XPENG‑W (9868.HK) finished the session up roughly ~18%, helping lift the Hang Seng even as chip names lagged.
  • U.S. trade runs hot: In pre‑market action, XPEV ranked among the most active issues, quoted around $27.15 before settling near $26 by early afternoon U.S. time.
  • Street chatter turns bullish: A Morgan Stanley note lifted its XPeng price target to $34 (from $30), citing improving fundamentals and AI optionality.
  • Market‑cap milestone in HK: At one point intraday, XPeng’s Hong Kong market value topped Geely’s, underscoring how quickly sentiment has swung toward XPeng’s AI roadmap.

Why the stock is jumping

1) Humanoid robot ‘IRON’ becomes a mainstream storyline.
XPeng’s next‑gen IRON took center stage after AI Day (Nov. 5). Coverage highlighted lifelike motion, real‑time interaction, and a plan to use solid‑state batteries in the robot platform, with mass production targeted by end‑2026. The spectacle even included a viral on‑stage demo to dispel “man‑in‑a‑suit” rumors. MotorTrend

2) Robotaxi launch path gets clearer.
XPeng has teamed up with Alibaba’s Amap to integrate its self‑developed robotaxis directly into China’s dominant mapping/ride‑hailing app, with trial operations slated for 2026. Separate reporting emphasizes XPeng’s end‑to‑end approach (chips, software, vehicles) as a potential cost edge when services scale.

3) Momentum into earnings.
Beyond the headlines, investors are front‑running next week’s print. The company will report Q3 2025 results on Monday, Nov. 17 at 8:00 a.m. ET, a catalyst now amplified by the AI narrative and robust delivery run‑rate.

By the numbers: the fundamentals behind the hype

  • Deliveries: XPeng delivered 116,007 vehicles in Q3 2025, up 149% YoY, and a record 42,013 units in October—its fourth straight monthly high.
  • Outlook (from prior guidance): In August, XPeng projected Q3 revenue up ~94%–108% YoY on 113,000–118,000 deliveries—targets consistent with the actual Q3 delivery tally.
  • Stock context: Over the past year, XPEV’s 52‑week range has been $11.15–$27.16, with today’s surge pushing toward the top end of that band.

What’s new today vs. last week’s AI Day

  • Official reveals (Nov. 5): XPeng unveiled VLA 2.0, the Robotaxi platform, Next‑Gen IRON, and two ARIDGE (flying‑systems) updates—an integrated “Physical AI” roadmap that links vehicles, robots, and aerial mobility. XPENG
  • Follow‑through media coverage (today): Automotive tech outlets and market news wires amplified those demos, helping spark today’s rally in Hong Kong and the U.S. ADR.

Street & market color from today

  • Analysts: Alongside the Morgan Stanley move to $34, several services flagged bullish options flow into the print. (As always, options‑led momentum can cut both ways.)
  • Price action superlatives: Multiple outlets called it XPeng’s best day in over two years and one of the sharpest one‑day moves since 2022, reflecting how AI narratives can re‑rate EV makers.

Earnings setup: what to watch on Nov. 17

  • Gross margin & mix: Whether the October record and the MONA M03/G6/G7 mix are improving unit economics as scale builds.
  • Software monetization: Progress on ADAS/“XNGP” attach rates and any early indications of robotaxi commercialization milestones. (WSJ and Reuters reporting points to 2026 pilot timing with Amap.) The Wall Street Journal
  • Capex & AI spend: Any updates on robotics investment cadence and partnerships (e.g., batteries, compute), following the company’s stated ambitions in humanoids.

Quick Facts (Nov. 11, 2025)

  • HK move: ~18% intraday jump for 9868.HK; Hang Seng finished modestly higher with XPENG‑W among the top contributors.
  • U.S. ADR: Heavy activity around $26–$27 during the U.S. session after a brisk pre‑market.
  • Fresh PT:$34 at Morgan Stanley (today).
  • Key near‑term date:Q3 results — Monday, Nov. 17, 8:00 a.m. ET.

The bottom line

Today’s surge wasn’t just another EV short squeeze—it was a broad re‑rating on XPeng’s “Physical AI” story: robots, robotaxis, and intelligent EVs under one roof. With record deliveries, a newly energized Street narrative, and a major earnings catalyst five trading days away, XPeng just moved from niche to front‑page in the global EV conversation. Execution on margins and a credible 2026 robotaxi path will determine whether the rerating sticks. Xiaopeng


Note: This article is for information purposes only and is not investment advice. Markets are volatile; always do your own research and consider seeking independent financial advice before making investment decisions.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • KalVista Pharmaceuticals Rises 39% on Acquisition Deal with Chiesi Group
    April 29, 2026, 6:37 PM EDT. KalVista Pharmaceuticals surged 38.62% to $26.67 after announcing its acquisition by Italy's Chiesi Group at $27 per share in cash. The deal sparked high trading volume, reaching 69.4 million shares, over 3,000% above average. KalVista, known for its oral therapy EKTERLY for hereditary angioedema, could benefit from Chiesi's global reach. The broader market was mixed: the S&P 500 dipped 0.02% to 7,138, while the Nasdaq edged up 0.04% to 24,673. Rival biotech stock Prothena dropped 5.56% amid investor caution over drug pipelines. KalVista's acquisition marks a shift for a company that faced heavy short interest and revenue challenges, positioning it for growth under Chiesi's ownership, pending regulatory approval.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
Sea Limited (SE) Q3 2025: Revenue Jumps 38% to $6B; EPS Misses Street View as Shopee Outlook Raised Above 25%
Previous Story

Sea Limited (SE) Q3 2025: Revenue Jumps 38% to $6B; EPS Misses Street View as Shopee Outlook Raised Above 25%

IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?
Next Story

IBM Stock Today (11/11/2025): Price Action, Fresh AI Partnerships, and Design Win Put IBM in Focus

Go toTop